/PRNewswire/ International Isotopes Inc. (OTCQB: INIS) (the "Company") announces its financial results for the fiscal year ended December 31, 2021. Total.
/PRNewswire/ International Isotopes Inc. (OTCQB: INIS) ("International Isotopes" or "INIS") has announced the completion of a modification to the term of.
/PRNewswire/ International Isotopes Inc. (OTCQB: INIS) ("International Isotopes" or "INIS") has announced the approval of a modification to the term of its.
Increasing acceptance of therapeutic nuclear medicines (or radiopharmaceuticals) among industry experts will remain a prominent factor encouraging their adoption. Though associated with a negligible risk factor, radiopharmaceuticals are likely to witness growing recommendation owing to no proven significant adverse.